Synephrine Content of Juice from Satsuma Mandarins (Citrus Unshiu Marcovitch)
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
DART-MS/MS Screening for the Determination of 1,3- Dimethylamylamine and Undeclared Stimulants in Seized Dietary Supplements from Brazil
Forensic Chemistry 8 (2018) 134–145 Contents lists available at ScienceDirect Forensic Chemistry journal homepage: www.elsevier.com/locate/forc DART-MS/MS screening for the determination of 1,3- dimethylamylamine and undeclared stimulants in seized dietary supplements from Brazil Maíra Kerpel dos Santos a, Emily Gleco b, J. Tyler Davidson b, Glen P. Jackson b, Renata Pereira Limberger a, ⇑ Luis E. Arroyo b, a Graduate Program of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Brazil b Department of Forensic & Investigative Science, West Virginia University, USA article info abstract Article history: 1,3-dimethylamylamine (DMAA) is an alkylamine with stimulating properties that has been used pre- Received 15 December 2017 dominantly as an additive in dietary supplements. DMAA is mostly consumed by professional athletes, Received in revised form 14 March 2018 and several doping cases reported since 2008 led to its prohibition by the World Anti-Doping Agency Accepted 18 March 2018 (WADA) in 2010. Adverse effects have indicated DMAA toxicity, and there is few data regarding its safety, Available online 22 March 2018 so it was banned by regulatory agencies from Brazil and the United States. Ambient ionization methods such as Direct Analysis in Real Time Tandem Mass Spectrometry (DART-MS/MS) are an alternative for Keywords: dietary supplements analysis, because they enable the analysis of samples at atmospheric pressure in 1,3-dimethylamylamine a very short time and with only minimal sample preparation. Therefore, the aim of this work was to DART-MS/MS Dietary supplements develop a methodology by DART-MS/MS to detect the presence of DMAA, ephedrine, synephrine, caffeine, Stimulants sibutramine, and methylphenidate in 108 dietary supplements seized by the Brazilian Federal Police Adulterants (BFP). -
"Performance of Citrus Scion Cultivars and Rootstocks in a High-Density
REPORTS HORTSCIENCE 26(7):837-840. 1991. house and planted in the field in 1981. A split plot experiment and analysis of variance Performance of Citrus Scion Cultivars (ANOVA) statistics were used with four rep- lications, with cultivar as the main plot and and Rootstock in a High-density rootstock as the subplot. Field plots were four ´ four trees, with data taken from the Planting center four of the 16 trees. They were planted 1.5 m in the row and 3.3 m between rows T.A. Wheaton, W.S. Castle, J.D. Whitney, and D.P.H. Tucker and were irrigated and fertigated as required Citrus Research and Education Center, University of Florida, Institute of to maintain optimal soil water and nutrient levels using one microsprinkler per two trees. Food and Agricultural Sciences, 700 Experiment Station Road, Lake Trees were mechanically hedged and topped Alfred, FL 33850 during Summer 1987 and hedged again in 1989 to maintain a 1.5-m alley between rows Additional index words. tree spacing, yield efficiency and a 2.5-m tree height. Thus, the canopy Abstract. ‘Hamlin’ and ‘Valencia’ oranges [Citrus sinensis (L.) Osb.], ‘Murcott’ tangor size allocated for each tree was 1.5 m in the (C. reticulata Blanco ´ C. sinensis), and ‘Redblush’ grapefruit (C. paradisi Macf.) on row, 1.8 m across the row, and 2.5 m in 15 rootstock and own-rooted cuttings were planted at a 1.5 ´ 3.3-m spacing providing height, providing 6.8 m3 of canopy volume a density of 2020 trees/ha. -
Known Host Plants of Huanglongbing (HLB) and Asian Citrus Psyllid
Known Host Plants of Huanglongbing (HLB) and Asian Citrus Psyllid Diaphorina Liberibacter citri Plant Name asiaticus Citrus Huanglongbing Psyllid Aegle marmelos (L.) Corr. Serr.: bael, Bengal quince, golden apple, bela, milva X Aeglopsis chevalieri Swingle: Chevalier’s aeglopsis X X Afraegle gabonensis (Swingle) Engl.: Gabon powder-flask X Afraegle paniculata (Schum.) Engl.: Nigerian powder- flask X Atalantia missionis (Wall. ex Wight) Oliv.: see Pamburus missionis X X Atalantia monophylla (L.) Corr.: Indian atalantia X Balsamocitrus dawei Stapf: Uganda powder- flask X X Burkillanthus malaccensis (Ridl.) Swingle: Malay ghost-lime X Calodendrum capense Thunb.: Cape chestnut X × Citroncirus webberi J. Ingram & H. E. Moore: citrange X Citropsis gilletiana Swingle & M. Kellerman: Gillet’s cherry-orange X Citropsis schweinfurthii (Engl.) Swingle & Kellerm.: African cherry- orange X Citrus amblycarpa (Hassk.) Ochse: djerook leemo, djeruk-limau X Citrus aurantiifolia (Christm.) Swingle: lime, Key lime, Persian lime, lima, limón agrio, limón ceutí, lima mejicana, limero X X Citrus aurantium L.: sour orange, Seville orange, bigarde, marmalade orange, naranja agria, naranja amarga X Citrus depressa Hayata: shiikuwasha, shekwasha, sequasse X Citrus grandis (L.) Osbeck: see Citrus maxima X Citrus hassaku hort. ex Tanaka: hassaku orange X Citrus hystrix DC.: Mauritius papeda, Kaffir lime X X Citrus ichangensis Swingle: Ichang papeda X Citrus jambhiri Lushington: rough lemon, jambhiri-orange, limón rugoso, rugoso X X Citrus junos Sieb. ex Tanaka: xiang -
Multi-Class Determination of 64 Illicit Compounds in Dietary Supplements Using Liquid Chromatography–Tandem Mass Spectrometry
molecules Article Multi-Class Determination of 64 Illicit Compounds in Dietary Supplements Using Liquid Chromatography–Tandem Mass Spectrometry Dasom Shin, Hui-Seung Kang *, Hyungsoo Kim and Guiim Moon New Hazardous Substances Division, Department of Food Safety Evaluation, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju 28159, Korea; [email protected] (D.S.); [email protected] (H.K.); [email protected] (G.M.) * Correspondence: [email protected] Received: 11 August 2020; Accepted: 17 September 2020; Published: 24 September 2020 Abstract: In this work, liquid chromatography–tandem mass spectrometry (LC-MS/MS) method was developed and validated for screening and confirmation of 64 illicit compounds in dietary supplements. The target compounds were illegally used pharmaceutical drugs, prohibited compounds, and not authorized ingredients for different therapeutics (sexual enhancement, weight loss, muscular strengthening, and relaxing products). The validation procedure was performed to evaluate selectivity, linearity, limit of detection (LOD), limit of quantification (LOQ), accuracy, and precision according to the Association of Official Analytical Chemists guidelines. The linearity was >0.98 in the range of 1 1 0.5–200 µg L− . The LOQs were in the range 1–10 µg kg− for all target compounds. The accuracy (expressed as recovery) was 78.5–114%. The precision (expressed as the relative standard deviation) was below 9.15%. The developed method was applied for the determination of illicit compounds in dietary supplements collected from websites. As a result, the total detection rate was 13.5% (27 samples detected in 200 samples). The concentrations of detected samples ranged from 0.51 1 to 226 mg g− . -
Marketing Standards for Citrus Fruits
COMMISSION IMPLEMENTING REGULATION (EU) No 543/2011 of 7 June 2011 laying down detailed rules for the application of Council Regulation (EC) No 1234/2007 in respect of the fruit and vegetables and processed fruit and vegetables sectors. CONSOLIDATED TEXT: Annex I; Part 2 of Part B MARKETING STANDARD FOR CITRUS FRUIT I. DEFINITION OF PRODUCE This standard applies to citrus fruit of varieties (cultivars) grown from the following species, to be supplied fresh to the consumer, citrus fruit for industrial processing being excluded: - lemons grown from the species Citrus limon (L.) Burm. f. and hybrids thereof, - mandarins grown from the species Citrus reticulata Blanco, including satsumas (Citrus unshiu Marcow), clementines (Citrus clementina hort. ex Tanaka), common mandarins (Citrus deliciosa Ten.) and tangerines (Citrus tangerina Tanaka) grown from these species and hybrids thereof, - oranges grown from the species Citrus sinensis (L.) Osbeck and hybrids thereof. II. PROVISIONS CONCERNING QUALITY The purpose of the standard is to define the quality requirements for citrus fruit after preparation and packaging. However, at stages following dispatch products may show in relation to the requirements of the standard: - a slight lack of freshness and turgidity, - for products graded in classes other than the “Extra” Class, a slight deterioration due to their development and their tendency to perish. A. Minimum requirements In all classes, subject to the special provisions for each class and the tolerances allowed, the citrus fruit must be: - intact, - free of bruising and/or extensive healed overcuts, CI.1 - sound; produce affected by rotting or deterioration such as to make it unfit for consumption is excluded, - clean, practically free of any visible foreign matter, - practically free from pests, - free from damage caused by pests affecting the flesh, - free of signs of shrivelling and dehydration, - free of damage caused by low temperature or frost, - free of abnormal external moisture, - free of any foreign smell and/or taste. -
Stimulant Medications and Supplements: Clinical Implications for the Sports Medicine Provider Collaborative Solutions for Safety in Sport
Stimulant Medications and Supplements: Clinical Implications for the Sports Medicine Provider Collaborative Solutions for Safety in Sport Francis G. O’Connor, MD, MPH, COL, MC, USA Professor and Chair, Military and Emergency Medicine Uniformed Services University of the Health Sciences DISCLOSURE . I have no relevant financial disclosures in reference to this lecture. That being said, I am a physician in the US Army, and work for the DoD. My opinions and assertions contained herein are private views and are not to be construed as official or as reflecting the views of the U.S. Army Medical Department , Uniformed Services University or the Department of Defense at large. Case Presentation 1 . 25 y/o soldier presents to the sports medicine clinic for heat tolerance testing and a return to duty assessment; . He sustained an exertional heat stroke (EHS) during Special Forces accession. Soldier was acclimatized with no history of EHS; he had been using a pre- workout stimulant. Case Presentation 2 . 25 y/o soldier presents to the medical aid station complaining of palpitations, agitation and insomnia. He has sinus tachycardia on the monitor and reports regular use of Red Bull and caffeine gum. Unit is requesting guidance on strategies for sleep. Case Presentation 3 . A warfighter contacts the Human Performance Resource Center looking for help. Recently using a new pre- workout supplement to enhance training. Unfortunately the soldier “popped positive” on a recent urine drug screen. Case Presentation 4 . Alison is a 19 y/o transfer female basketball player. She states she has a personal history of ADHD and would like to renew her prescription for Ritalin. -
Chiral Separation for Enantiomeric Determination in the Pharmaceutical Industry
Chapter CHIRAL SEPARATION FOR ENANTIOMERIC DETERMINATION IN THE PHARMACEUTICAL INDUSTRY Nelu Grinberg, Su Pan Contents 6.1. INTRODUCTION ...................................................................................................................................... 235 6.2. ENANTIOMERS, DIASTEREOMERS, RACEMATES ................................................................... 236 6.3. REQUIREMENTS FOR CHIRAL SEPARATION ............................................................................ 237 6.4. THE TYPES OF MOLECULAR INTERACTIONS ........................................................................... 237 6.4.1. Chiral separation through hydrogen bonding ............................................................. 237 6.4.2. Chiral separation through inclusion compounds ....................................................... 243 6.4.2.1. Cyclodextrins ............................................................................................................ 243 6.4.2.2. Crown ethers ............................................................................................................. 245 6.4.3. Charge transfer .......................................................................................................................... 259 6.4.4. Chiral separation through a combination of charge transfer, hydrogen bonding and electrostatic interactions ........................................................................... 260 233 Chapter 6 6.4.5. Ligand exchange ...................................................................................................................... -
Known Host Plants of Huanglongbing (HLB) and Asian Citrus Psyllid
Known Host Plants of Huanglongbing (HLB) and Asian Citrus Psyllid Diaphorina Liberibacter citri Plant Name asiaticus Citrus Huanglongbing Psyllid Aegle marmelos (L.) Corr. Serr.: bael, Bengal quince, golden apple, bela, milva X Aeglopsis chevalieri Swingle: Chevalier’s aeglopsis X X Afraegle gabonensis (Swingle) Engl.: Gabon powder-flask X Afraegle paniculata (Schum.) Engl.: Nigerian powder- flask X Artocarpus heterophyllus Lam.: jackfruit, jack, jaca, árbol del pan, jaqueiro X Atalantia missionis (Wall. ex Wight) Oliv.: see Pamburus missionis X X Atalantia monophylla (L.) Corr.: Indian atalantia X Balsamocitrus dawei Stapf: Uganda powder- flask X X Burkillanthus malaccensis (Ridl.) Swingle: Malay ghost-lime X Calodendrum capense Thunb.: Cape chestnut X × Citroncirus webberi J. Ingram & H. E. Moore: citrange X Citropsis gilletiana Swingle & M. Kellerman: Gillet’s cherry-orange X Citropsis schweinfurthii (Engl.) Swingle & Kellerm.: African cherry- orange X Citrus amblycarpa (Hassk.) Ochse: djerook leemo, djeruk-limau X Citrus aurantiifolia (Christm.) Swingle: lime, Key lime, Persian lime, lima, limón agrio, limón ceutí, lima mejicana, limero X X Citrus aurantium L.: sour orange, Seville orange, bigarde, marmalade orange, naranja agria, naranja amarga X Citrus depressa Hayata: shiikuwasha, shekwasha, sequasse X Citrus grandis (L.) Osbeck: see Citrus maxima X Citrus hassaku hort. ex Tanaka: hassaku orange X Citrus hystrix DC.: Mauritius papeda, Kaffir lime X X Citrus ichangensis Swingle: Ichang papeda X Citrus jambhiri Lushington: rough lemon, jambhiri-orange, limón rugoso, rugoso X X Citrus junos Sieb. ex Tanaka: xiang cheng, yuzu X Citrus kabuchi hort. ex Tanaka: this is not a published name; could they mean Citrus kinokuni hort. ex Tanaka, kishu mikan? X Citrus limon (L.) Burm. -
High Biological Value Compounds Extraction from Citrus Waste with Non-Conventional Methods
foods Review High Biological Value Compounds Extraction from Citrus Waste with Non-Conventional Methods Mayra Anticona, Jesus Blesa , Ana Frigola and Maria Jose Esteve * Nutrition and Food Chemistry, University of Valencia, Avda., Vicent Andrés Estellés, s/n., 46100 Burjassot, Spain; [email protected] (M.A.); [email protected] (J.B.); [email protected] (A.F.) * Correspondence: [email protected]; Tel.: +34-963544913 Received: 27 April 2020; Accepted: 15 June 2020; Published: 20 June 2020 Abstract: Citrus fruits are extensively grown and much consumed around the world. Eighteen percent of total citrus cultivars are destined for industrial processes, and as a consequence, large amounts of waste are generated. Citrus waste is a potential source of high biological value compounds, which can be used in the food, pharmaceutical, and cosmetic industries but whose final disposal may pose a problem due to economic and environmental factors. At the same time, the emerging need to reduce the environmental impact of citrus waste and its responsible management has increased. For these reasons, the study of the use of non-conventional methods to extract high biological value compounds such as carotenoids, polyphenols, essential oils, and pectins from this type of waste has become more urgent in recent years. In this review, the effectiveness of technologies such as ultrasound assisted extraction, microwave assisted extraction, supercritical fluid extraction, pressurized water extraction, pulsed electric field, high-voltage electric discharges, and high hydrostatic pressures is described and assessed. A wide range of information concerning the principal non-conventional methods employed to obtain high-biological-value compounds from citrus waste as well as the most influencing factors about each technology are considered. -
The Satsuma Mandarin1 Peter C
HS195 The Satsuma Mandarin1 Peter C. Andersen and James J. Ferguson2 Scientific Name Family Citrus unshiu Marcovitch Rutaceae Common Name Origin In most citrus producing areas, satsuma mandarin is the China and Japan preferred name, but satsuma tangerine is also used (Figures 1 and 2). Distribution Satsumas are grown in cool subtropical regions of Japan, Spain, central China, Korea, Turkey, along the Black Sea in Russia, southern South Africa, South America, and on a small scale in central California and northern Florida. The world’s largest satsuma industry is located in southern Ja- pan where climatic conditions are favorable for the produc- tion of early ripening satsuma mandarins of high quality. Selection of slight mutations and seedlings from controlled pollinations over many years has resulted in a collection of Figure 1. A satsuma orchard in north Florida. over 100 cultivars that differ in date of maturity, fruit shape, Credits: P. C. Andersen color, and quality. ‘Owari’ is the primary satsuma cultivar commercially grown in Florida, but ‘Brown Select’, ‘Early St. Ann’, ‘Silverhill’, and ‘Kimbrough’ are also available. History Satsuma mandarin may have originated in China, but it was first reported in Japan more than 700 years ago, where it is now the major citrus species grown. The first recorded introduction into the United States was in Florida by George R. Hall in 1876. The name “satsuma” is credited to Figure 2. Mature satsumas ready for harvest. the wife of a United States minister to Japan, General Van Credits: P. C. Andersen 1. This document is HS195, one of a series of the Horticultural Sciences Department, UF/IFAS Extension. -
Methedrine, Neo-Synephrine, Paredrine, and Pholedrine
Br Heart J: first published as 10.1136/hrt.6.4.214 on 1 October 1944. Downloaded from CLINICAL EVALUATION OF THE PRESSOR ACTIVITY OF METHEDRINE, NEO-SYNEPHRINE, PAREDRINE, AND PHOLEDRINE BY FREDERICK PRESCOTT From the Wellcome Research Institution, London Received October 10, 1944 Recently a number of pressor drugs of the adrenaline type have come into clinical use for the treatment of low blood pressure following surgical procedures, spinal anxsthesia, circu- latory collapse, and surgical and traumatic shock. For therapeutic purposes the ideal pressor drug should be effective by the intramuscular or intravenous route; it should act rapidly; it should produce a sustained elevation of blood pressure, so that frequent injections of the drug are not necessary; and it should have no undesirable effects on the cardiovascular system and no untoward side effects. Adrenaline and ephedrine were the first drugs to be used clinically to raise the blood pressure in cases of operative shock. Their limitations, however, are nowv well known. Adrenaline may do more harm than good beca4se in thera- peutic doses intrayenously it causes a considerable rise of blood pressure, e.g. 200 mm. to 300 mm. of mercury, with a precipitous fall after a few minutes to a level lower than before. Similarly ephedrine, which for dependable results must be given intravenously, produces a http://heart.bmj.com/ sharp rise of blood pressure that lasts only for ten to twenty minutes. Other pressor drugs have been introduced with a more sustained action. In most of the studies reported on these, however, no definite criteria seem to have been employed in their evaluation, nor have the conditions of administration been standardized. -
Ep 3311667 A1
(19) TZZ¥¥___T (11) EP 3 311 667 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 25.04.2018 Bulletin 2018/17 A01N 43/42 (2006.01) A61K 31/44 (2006.01) (21) Application number: 17194444.0 (22) Date of filing: 08.07.2010 (84) Designated Contracting States: • SCHACHTEL, Bernard AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Jupiter, FL Florida 33477 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • TAKIGIKU, Ray PL PT RO SE SI SK SM TR Loveland, OH Ohio 45140 (US) (30) Priority: 08.07.2009 US 223999 P (74) Representative: Avidity IP 09.07.2009 US 224424 P Broers Building Hauser Forum (62) Document number(s) of the earlier application(s) in 21 JJ Thomson Avenue accordance with Art. 76 EPC: Cambridge CB3 0FA (GB) 10797879.3 / 2 451 274 Remarks: (71) Applicant: Charleston Laboratories, Inc. •This application was filed on 02-10-2017 as a Jupiter, FL 33477 (US) divisional application to the application mentioned under INID code 62. (72) Inventors: •Claims f iled aft er the date of fil ing of the • BOSSE, Paul application/after the date of receipt of the divisional Jupiter, FL Florida 33469 (US) application (Rule 68(4) EPC) • AMELING, John Cincinnati, OH 45252-1051 (US) (54) PHARMACEUTICAL COMPOSITIONS (57) Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic. EP 3 311 667 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 311 667 A1 Description CROSS-REFERENCE 5 [0001] This application claims the benefit of U.S.